Most people treating chronic pain find a workable range between 1:1 and 4:1 CBD to THC by milligram. Ratios closer to 1:1 ease pain more reliably in trials that used THC-containing extracts. Ratios of 10:1 and above limit intoxication and allow daytime dosing, at the cost of weaker analgesia. Start low, hold the ratio steady for a week, then change one variable at a time.
best medical strains for chronic pain
How to read a CBD to THC ratio
A ratio compares milligrams, not drops, puffs, or grams of flower. A 4:1 oil contains 4 mg CBD for every 1 mg THC. A 1:1 product delivers equal amounts of each. The ratio says nothing about total dose. A 20:1 tincture can still carry 5 mg THC per milliliter, which is enough to impair someone who has never used cannabis. Read the label for milligrams per serving, then use the ratio as a second data point.
Is Medical Cannabis Better Than Gabapentin for Pain? A Practical Guide
Ratios and what they do
1:1
Equal parts CBD and THC. This is the closest match to products that produced pain reduction in controlled trials. Expect intoxication, dry mouth, and slowed reaction time. Best reserved for evening use or for people with prior cannabis experience.
how medical marijuana helps nerve pain
2:1 to 4:1
CBD blunts some THC effects without erasing them. This is the most common daytime-to-evening range reported by chronic pain users. Impairment is lower than at 1:1 for the same THC dose.
best medical strains for chronic pain
10:1 and above
Little to no intoxication for most people. Direct evidence for pain relief is thinner here, though CBD may help with the inflammation and anxiety that amplify pain. A sensible starting point if you cannot be impaired at work or behind the wheel.
CBD only
No THC at all. Worth a trial for mild or neuropathic discomfort, and the only option when THC is off the table. Many users find it insufficient for moderate to severe pain.
Before you start
- A clinician who knows your full medication list
- A product with a batch certificate of analysis listing CBD and THC in milligrams
- A dosing log for pain scores and side effects
- A measured dropper or scale
How to choose and titrate a ratio
- Pick a starting ratio. Choose 20:1 if you have never used THC, 4:1 if you have used it a few times, and 1:1 if you already use THC without trouble.
- Set a starting dose of 2.5 mg to 5 mg THC plus the matching CBD amount. At 4:1, that is 5 mg THC with 20 mg CBD.
- Take the dose at the same time each evening.
- Wait 7 days before changing anything.
- Log pain score, sleep hours, and side effects each day.
- Raise THC by 2.5 mg if pain is unchanged and side effects are mild.
- Hold the dose once pain drops by roughly 30 percent or side effects appear.
- Shift the ratio toward CBD if you feel too intoxicated at a dose that controls pain.
- Shift toward THC if pain persists on a CBD-heavy ratio and you tolerate THC well.
- Move to daytime dosing only after you know how you respond.
Timing and route
Oral oils peak in 1 to 3 hours and last 6 to 8 hours. Inhaled products peak within minutes and fade in 2 to 3 hours. The same ratio behaves differently by route, so keep the route fixed while you titrate. Do not stack an edible and a vape on the same evening while you are still finding your dose.
Side effects and interactions
THC causes drowsiness, dizziness, a racing heart, and short-term memory problems at higher doses. CBD can raise blood levels of some drugs through liver enzyme effects, including warfarin, clobazam, and certain anticonvulsants. Both compounds add to the effects of alcohol and sedatives. Stop and contact a clinician if you develop chest pain, severe confusion, or fainting.
What the evidence supports
A 2015 meta-analysis in JAMA found that cannabinoids produced modest pain reduction compared with placebo across chronic pain conditions. A 2017 National Academies review found substantial evidence for cannabis in chronic pain. Most of those trials used THC-dominant products and did not compare ratios head to head, so ratio guidance comes from pharmacology and clinical practice rather than direct trials. The FDA has not approved cannabis for the treatment of chronic pain.